Intelligence Β· Patent portfolio
United Therapeutics Europe Patents
Full USPTO pharma patent portfolio for United Therapeutics Europe β grant dates, expiration, and drug cross-links.
- Patents
- 3,720
- Expiring β€24m
- 234
Quick answer
United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β use filters for patent-cliff planning.
-
US 6639060
erbB-3 nucleic acids
expired -
US 6638514
Multivalent dengue virus vaccine
expired -
US 6635614
Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol
expired -
US 6632808
Inhibitors of amyloid formation
expired -
US 6632437
Immunogenic polysaccharide-protein conjugates containing poly &agr;(2→8), &agr;(2→9) NeuNAc capsular polysaccharides
expired -
US 6632789
Methods for modulating T cell responses by manipulating intracellular signal transduction
expired -
US 6632640
Vaccine against Staphylococcus intoxication
expired -
US 6632928
Immunotoxins and methods of inducing immune tolerance
expired -
US 6630144
Monoclonal antibodies to Ebola glycoprotein
expired -
US 6630507
Cannabinoids as antioxidants and neuroprotectants
expired -
US 6630124
Combination therapy with VIP antagonist
expired -
US 6630464
Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer
expired -
US 6630167
Hyaluronic acid anti-adhesion barrier
expired -
US 6627641
Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
expired -
US 6623952
Spumavirus isolated from humans
expired -
US 6620412
Prophylactic and therapeutic monoclonal antibodies
expired -
US 6620913
Polypeptides of a novel hantavirus
expired -
US 6617161
Serum-free cell growth medium
expired -
US 6613764
Aspartic protease inhibitors
expired -
US 6613883
Screening assays for compounds that cause apoptosis and related compounds
expired -
US 6613556
Adaptation of virus to vertebrate cells
expired -
US 6613740
Activity dependent neurotrophic factor III (ADNF III)
expired -
US 6610476
Detection of HIV-1 DNA
expired -
US 6610660
O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates
expired -
US 6610684
Fused azepinone cyclin dependent kinase inhibitors
expired -
US 6607725
Conjugate vaccine for nontypeable Haemophilus influenzae
expired -
US 6605619
Nitroxides as protectors against oxidatives stress
expired -
US 6602979
Screening assays for compounds that cause apoptosis
expired -
US 6599449
X-ray crystallography reagent
expired -
US 6599739
Infectious papillomavirus pseudoviral particles
expired -
US 6600018
Secreted frizzled related protein, sFRP, fragments and methods of use thereof
expired -
US 6600030
Delayed progression to aids by a missense allele of the CCR2 gene
expired -
US 6596923
Methods and compositions to identify swine genetically resistant to F18 E. coli associated diseases
expired -
US 6596269
Methods of treating chronic pain
expired -
US 6596690
Vasostatin as marrow protectant
expired -
US 6592872
Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein
expired -
US 6586392
Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins
expired -
US 6586413
Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
expired -
US 6586628
3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same
expired -
US 6582699
Combination vaccine for enhancing immunity against brucellosis
expired -
US 6579848
Depigmenting activity of agouti signal protein and peptides thereof
expired -
US 6572864
Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
expired -
US 6573244
Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
expired -
US 6569897
Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
expired -
US 6566098
DNA encoding truncated hepatocyte growth factor variants
expired -
US 6565853
Recombinant virus
expired -
US 6562376
DNA vaccines against poxviruses
expired -
US 6562859
Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation
expired
Frequently asked questions
How many patents does United Therapeutics Europe have?
3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do United Therapeutics Europe patents expire?
234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory